Listed by the USPTO as BURKETT, DANIEL JOHN
Tech Center 3600 • Art Units: 1600 1621 1624 1625 1626 3646
This examiner grants 64% of resolved cases
This examiner is in Tech Center 3600 and Art Unit 1600, with 104 resolved cases. The allowance rate is 64.4%, and the median time to allowance is 1219 days. The 32.8% interview lift supports treating interviews as a meaningful component of prosecution strategy.
The principal companies are Institut National de La Sante Et de La Recherche Medicale, The Regents of the University of California, and Hoffmann-La Roche Inc. The leading firms are Conley Rose, P.C., BELL & ASSOCIATES, and Casimir Jones, S.C. Practitioners may combine interview preparation with detailed written responses tailored to the technical record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18855254 | COMBINATION METABOLIC-EPIGENETIC TREATMENT FOR EARLY LUNG CANCER | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18993989 | NOVEL ISOTHIAZOL-3-YL AND ISOXAZOL-3-YL SULFONAMIDE COMPOUNDS | Non-Final OA | Hoffmann-La Roche Inc. |
| 18691241 | MEDICAMENT FOR PREVENTING AND/OR TREATING DRY EYE | Final Rejection | Boehringer Ingelheim International GMBH |
| 18022962 | MODULATORS OF MYB-MEDIATED TRANSCRIPTION AND USES THEREOF | Final Rejection | Massachusetts Institute of Technology |
| 18283264 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | Non-Final OA | DANA-FARBER CANCER INSTITUTE, INC. |
| 18653324 | PENTAMIDINE ANALOGS | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 18176877 | INHIBITION OF URACIL DNA GLYCOSYLASE IN THE OPEN CONFORMATION | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 18251101 | CRYSTALLINE FORM II OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR | Non-Final OA | LG CHEM, LTD. |
| 18568761 | COMPOUND AS CDK KINASE INHIBITOR AND USE THEREOF | Non-Final OA | TYK MEDICINES, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy64.4% of resolved applications examined by Daniel John Burkett were allowed (104 resolved cases), compared with 36.5% across Art Unit 1600 over the last five years.
This examiner's interview lift is +32.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Daniel John Burkett took 1,219 days on average from filing to allowance.
Daniel John Burkett examines applications in Art Unit 1600 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).